{"_avots":{"nosaukums":"Saraksts.lv","lapa":"https://saraksts.lv/40203191683","dati_atjaunoti":"2026-09-22","piezime":"Neoficiāls apkopojums no valsts atvērtajiem datiem (UR, VID u. c. iestādes, data.gov.lv). Oficiālais pirmavots: info.ur.gov.lv","licence":"CC-BY-4.0","licence_url":"https://creativecommons.org/licenses/by/4.0/","licences_tverums":"Saraksts.lv aprēķini un apkopojums. Avota ieraksti (raw_database_records) — CC0 1.0. Uz fizisko personu datiem licence neattiecas.","licences_skaidrojums":"https://saraksts.lv/dati.php#licence","atsauce":"Avots: Saraksts.lv (CC BY 4.0), https://saraksts.lv/40203191683"},"registration_number":"40203191683","company_name":"SIA \"PHARM PRINCIPLE\"","company_type":"SIA","registered_date":"2019-01-24","area_of_activity":{"nace_code":"8569","nace_description":"Citur neklasificēti izglītības atbalsta pakalpojumi"},"segmentation":{"status":"Aktīvs","form_group":"Komercsabiedrība","financials":"Zaudējumi"},"financial_summary":{"UGP":{"columns":["year","turnover","profit","assets","employees","currency"],"data":[[2024,0,-50,550,0,"EUR"],[2023,0,-50,550,0,"EUR"],[2022,0,-50,550,0,"EUR"],[2021,0,-61,550,0,"EUR"],[2020,0,-50,550,0,"EUR"]]}},"detailed_financials_by_year":{"2024":{"UGP":{"fs_data":{"currency":"EUR","employees":0,"type_from_db":"UGP"},"income_data":{"net_turnover":0,"provision_for_income_taxes":50,"income_after_income_taxes":-50,"net_income":-50},"balance_data":{"cash":550,"cur_assets":550,"assets":550,"cur_liab":261,"equity":289,"equities":550},"sankey_prepared":{"nodes":{"columns":["name"],"data":[["EBT"],["UIN Nodoklis"],["Tīrā Peļņa (Zaudējumi)"]]},"links":{"columns":["source","target","value","originalValue","isLoss"],"data":[["ebt_calc","tax_exp",50,50,false],["ebt_calc","net_income_final",50,-50,true]]}},"financial_ratios":{"current_ratio":{"value":2.10727969348659},"quick_ratio":{"value":2.10727969348659},"roa":{"value":-0.09090909090909091},"roe":{"value":-0.17301038062283736},"debt_to_equity":{"value":0.903114186851211,"negative_equity":false},"altman_z_score":{"value":1.286868380355277}},"source_ids":{"financial_statement_id":"2099075","income_statement_id":"2099075","balance_sheet_id":"2099075"}}},"2023":{"UGP":{"fs_data":{"currency":"EUR","employees":0,"type_from_db":"UGP"},"income_data":{"net_turnover":0,"provision_for_income_taxes":50,"income_after_income_taxes":-50,"net_income":-50},"balance_data":{"cash":550,"cur_assets":550,"assets":550,"cur_liab":211,"equity":339,"equities":550},"sankey_prepared":{"nodes":{"columns":["name"],"data":[["EBT"],["UIN Nodoklis"],["Tīrā Peļņa (Zaudējumi)"]]},"links":{"columns":["source","target","value","originalValue","isLoss"],"data":[["ebt_calc","tax_exp",50,50,false],["ebt_calc","net_income_final",50,-50,true]]}},"financial_ratios":{"current_ratio":{"value":2.6066350710900474},"quick_ratio":{"value":2.6066350710900474},"roa":{"value":-0.09090909090909091},"roe":{"value":-0.14749262536873156},"debt_to_equity":{"value":0.6224188790560472,"negative_equity":false},"altman_z_score":{"value":1.6387794571305472}},"source_ids":{"financial_statement_id":"2099067","income_statement_id":"2099067","balance_sheet_id":"2099067"}}},"2022":{"UGP":{"fs_data":{"currency":"EUR","employees":0,"type_from_db":"UGP"},"income_data":{"net_turnover":0,"provision_for_income_taxes":50,"income_after_income_taxes":-50,"net_income":-50},"balance_data":{"cash":550,"cur_assets":550,"assets":550,"cur_liab":161,"equity":389,"equities":550},"sankey_prepared":{"nodes":{"columns":["name"],"data":[["EBT"],["UIN Nodoklis"],["Tīrā Peļņa (Zaudējumi)"]]},"links":{"columns":["source","target","value","originalValue","isLoss"],"data":[["ebt_calc","tax_exp",50,50,false],["ebt_calc","net_income_final",50,-50,true]]}},"financial_ratios":{"current_ratio":{"value":3.4161490683229814},"quick_ratio":{"value":3.4161490683229814},"roa":{"value":-0.09090909090909091},"roe":{"value":-0.12853470437017994},"debt_to_equity":{"value":0.4138817480719794,"negative_equity":false},"altman_z_score":{"value":2.1209571541501977}},"source_ids":{"financial_statement_id":"2099065","income_statement_id":"2099065","balance_sheet_id":"2099065"}}},"2021":{"UGP":{"fs_data":{"currency":"EUR","employees":0,"type_from_db":"UGP"},"income_data":{"net_turnover":0,"interest_expenses":11,"income_before_income_taxes":-11,"provision_for_income_taxes":50,"income_after_income_taxes":-61,"net_income":-61},"balance_data":{"cash":550,"cur_assets":550,"assets":550,"cur_liab":111,"equity":439,"equities":550},"sankey_prepared":{"nodes":{"columns":["name"],"data":[["EBT"],["Procentu Izmaksas"],["UIN Nodoklis"],["Tīrā Peļņa (Zaudējumi)"]]},"links":{"columns":["source","target","value","originalValue","isLoss"],"data":[["ebt_calc","interest_exp",11,11,false],["ebt_calc","tax_exp",50,50,false],["ebt_calc","net_income_final",61,-61,true]]}},"financial_ratios":{"current_ratio":{"value":4.954954954954955},"quick_ratio":{"value":4.954954954954955},"roa":{"value":-0.11090909090909092},"roe":{"value":-0.13895216400911162},"debt_to_equity":{"value":0.2528473804100228,"negative_equity":false},"altman_z_score":{"value":2.9094374447174447}},"source_ids":{"financial_statement_id":"1393163","income_statement_id":"1393163","balance_sheet_id":"1393163"}}},"2020":{"UGP":{"fs_data":{"currency":"EUR","employees":0,"type_from_db":"UGP"},"income_data":{"net_turnover":0,"provision_for_income_taxes":50,"income_after_income_taxes":-50,"net_income":-50},"balance_data":{"cash":550,"cur_assets":550,"assets":550,"cur_liab":50,"equity":500,"equities":550},"sankey_prepared":{"nodes":{"columns":["name"],"data":[["EBT"],["UIN Nodoklis"],["Tīrā Peļņa (Zaudējumi)"]]},"links":{"columns":["source","target","value","originalValue","isLoss"],"data":[["ebt_calc","tax_exp",50,50,false],["ebt_calc","net_income_final",50,-50,true]]}},"financial_ratios":{"current_ratio":{"value":11},"quick_ratio":{"value":11},"roa":{"value":-0.09090909090909091},"roe":{"value":-0.1},"debt_to_equity":{"value":0.1,"negative_equity":false},"altman_z_score":{"value":5.621818181818182}},"source_ids":{"financial_statement_id":"1300556","income_statement_id":"1300556","balance_sheet_id":"1300556"}}}},"vid_data":{"has_data":true,"rating":{"Reitings":"N","Skaidrojums":"Neaktīvs nodokļu maksātājs","Informacijas_atjaunosanas_datums":"12.08.2026"},"quarterly_taxes":{"columns":["Taksacijas_gads_ceturksnis","Samaksato_VID_administreto_nodoklu_kopsumma_tukst_EUR","Taja_skaita_IIN","Taja_skaita_VSAOI","avg_gross_salary","avg_net_salary"],"data":[["2025. gada 4. ceturksnis","0.21","0.00","0.00","—","—"]]}},"raw_database_records":{"equity_capitals":{"columns":["equity_capital_type","amount","currency","date_from"],"data":[["PAID_UP_EQUITY",500,"EUR","2019-01-24"]]},"financial_statements":{"columns":["year","employees","currency"],"data":[[2019,0,"EUR"],[2020,0,"EUR"],[2021,0,"EUR"],[2022,0,"EUR"],[2023,0,"EUR"]]},"memorandum_date":{"columns":["document_date"],"data":[["2019-01-17"]]},"register":{"columns":["sepa","regtype","type","registered","address","index","addressid","city","atvk"],"data":[["LV82ZZZ40203191683","K","SIA","2019-01-24","Jelgava, Lielā iela 3 - 22",3001,116462832,100003028,"0090000"]]},"pdb_nm_komersantu_samaksato_nodoklu_kopsumas_odata":{"columns":["Taksacijas_gads","Uznemejdarbibas_forma","Pamatdarbibas_NACE_kods","Juridiska_adrese_ATVK_kods","Juridiska_adrese_ATVK_nosaukums","Samaksato_VID_administreto_nodoklu_kopsumma_tukst_EUR","Taja_skaita_IIN","Taja_skaita_VSAOI"],"data":[[2024,"sabiedrība ar ierobežotu atbildību","8569  ","003000","Jelgava","0.00","0.00","0.00"],[2023,"sabiedrība ar ierobežotu atbildību","8560  ","003000","Jelgava","0.00","0.00","0.00"]]},"reitings_uznemumi":{"columns":["Reitings","Skaidrojums","Informacijas_atjaunosanas_datums"],"data":[["N","Neaktīvs nodokļu maksātājs","12.08.2026"]]},"pdb_samaksato_nodoklu_kopsummas_cet":{"columns":["Nosaukums","Taksacijas_gads_ceturksnis","Samaksato_VID_administreto_nodoklu_kopsumma_tukst_EUR","Taja_skaita_PVN_iemaksa","Taja_skaita_PVN_atmaksa","Taja_skaita_IIN_summa","Taja_skaita_VSAOI_summa","Videjais_nodarbinato_personu_skaits_cilv"],"data":[["PHARM PRINCIPLE SIA","2025. gada 4. ceturksnis","0.21","0.00","0.00","0.00","0.00","0"],["PHARM PRINCIPLE SIA","2026. gada 1. ceturksnis","0.00","0.00","0.00","0.00","0.00","0"],["PHARM PRINCIPLE SIA","2026. gada 2. ceturksnis","0.0","0.0","0.0","0.0","0.0","0"]]},"income_statements":{"columns":["net_turnover","income_before_income_taxes","income_after_income_taxes","net_income","provision_for_income_taxes","interest_expenses"],"data":[[50,50,50,50,null,null],[0,null,-50,-50,50,null],[0,-11,-61,-61,50,11],[0,null,-50,-50,50,null],[0,null,-50,-50,50,null]]},"balance_sheets":{"columns":["cash","cur_assets","assets","equity","equities","cur_liab"],"data":[[550,550,550,550,550,null],[550,550,550,500,550,50],[550,550,550,439,550,111],[550,550,550,389,550,161],[550,550,550,339,550,211]]}}}